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Abstract The spatial separation of mRNA synthesis from
translation, while providing eukaryotes with the possibility to
achieve higher complexity through a more elaborate regulation of
gene expression, has set the need for transport mechanisms
through the nuclear envelope. In a simplistic view of nucleocy-
toplasmic transport, nuclear proteins are imported into the
nucleus while RNAs are exported to the cytoplasm. The reality
is, however, that transport of either proteins or RNAs across the
nuclear envelope can be bi-directional. During the past years, an
increasing number of proteins have been identified that shuttle
continuously back and forth between the nucleus and the
cytoplasm. The emerging picture is that shuttling proteins are
key factors in conveying information on nuclear and cytoplasmic
activities within the cell. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Standard microscopic and biochemical methods impose an
important constraint on localizing a protein to the nucleus or
to the cytoplasm. Due to sensitivity limits, these methods only
reveal the presence of a protein where its steady state concen-
tration is above the detection threshold. Finding that a pro-
tein is exclusively detected in the nucleus by immuno£uores-
cence or immunoblotting does not exclude the possibility that
the protein transiently crosses the nuclear envelope and plays
a role in the cytoplasm, or vice versa. Thus, appropriate as-
says had to be developed in order to speci¢cally analyze nu-
cleocytoplasmic shuttling (Fig. 1).
The ¢rst observations indicating that proteins can shuttle
continuously between the nucleus and the cytoplasm date as
far back as the 1950s [1] (see Fig. 1). However, it took ap-
proximately 30 years for the ¢rst shuttling protein, nucleolin,
to be identi¢ed [2]. At present, the list of nucleocytoplasmic
shuttling proteins includes transport receptors and adaptors
[3,4], steroid hormone receptors ([5] and references therein),
transcription factors [6], cell cycle regulators [7,8] and numer-
ous RNA binding proteins [4,9].
Nucleolin is a slow shuttling protein, which is not com-
pletely retained in the nucleus and therefore ‘leaks’ to the
cytoplasm [10]. Studies on the nucleocytoplasmic shuttling
of nucleolin led to the proposal that all nuclear proteins
have the ability to be exported from the nucleus. In the ab-
sence of speci¢c intranuclear retention mechanisms, all nu-
clear proteins were predicted to shuttle [10,11]. More recently,
however, novel classes of shuttling proteins were discovered
that move in and out of the nucleus much faster than nucle-
olin. Indeed, while nucleolin takes about 24 h to be detected
in a heterologous nucleus, shuttling of nucleocytoplasmic
transport factors is detected within minutes. The rapid trans-
port of fast shuttling proteins relies on the presence of con-
served signal sequences recognized by speci¢c receptors and
adaptors, which e⁄ciently translocate cargo through the nu-
clear envelope (for recent reviews see [4,3,12]). Shuttling pro-
teins typically have both a nuclear localization signal (NLS),
and a nuclear export signal (NES). Several types of signals
have been identi¢ed that interact with distinct transport path-
ways. Some signals can be recognized by a variety of receptors
and adaptors, and a given transport receptor can have distinct
binding sites for di¡erent signals. In some cases, the same
amino acid sequence confers both import and export activ-
ities.
A potential role of shuttling proteins in nucleocytoplasmic
transport was ¢rst proposed by Goldstein [1]. At present, it is
well established that shuttling proteins act not only as carriers
of cargo in transit between the nucleus and the cytoplasm, but
they also play an important role in relaying information be-
tween the two major cellular compartments.
2. Shuttling of nucleocytoplasmic transport receptors and
adaptors
Transport between the nucleus and the cytoplasm takes
place through the nuclear pore complex (NPC). In order to
cross the NPC, each cargo must contain de¢ned signal se-
quences, which are speci¢cally recognized by transport recep-
tors and adaptors (for recent reviews see [3,4,13,14]). Shortly
after traversing the NPC, importins (import receptors) and
exportins (export receptors) free their cargo and recycle, mov-
ing back to the other side of the nuclear envelope to start a
new transport event (Fig. 2). Thus, transport receptors and
adaptors are shuttling proteins that move rapidly back and
forth across the NPC.
The majority of known transport receptors belong to the
importin L super-family of RanGTP binding proteins. Cargo
binding by these receptors may be direct or mediated by a
speci¢c adaptor [3]. Importin L, for instance, uses importin K
as adaptor to mediate the import of proteins containing a
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classical NLS. The same receptor, importin L, is involved in
the import of snRNPs through a distinct adaptor, Snurportin-
1. Importin L can also function without an adaptor in the
import of some ribosomal proteins, the HIV-1 Rev and Tat
proteins, and probably cyclin B1. Exportin 1/CRM1, the best
characterized export receptor, may either directly recognize
the leucine-rich NES sequence present in a protein cargo, or
act through adaptor molecules [3]. For instance, export of
snRNAs requires an adaptor, PHAX, which mediates inter-
action of the monomethyl cap structure with exportin 1 (Fig.
2B). Thus, adaptor molecules have an important role in de-
termining cargo speci¢city. Transport of adaptors unbound to
a cargo is reduced by the cooperative binding of cargo, adap-
tor and receptor molecules, and recycling of adaptor mole-
cules also involves speci¢c receptors.
The small GTPase Ran is a crucial element in nucleocyto-
Fig. 1. Experimental approaches to identify shuttling proteins. A: Nuclear transfer experiments of Amoeba nuclei led Goldstein to postulate
that proteins can shuttle between nucleus and cytoplasm [1]. In this assay, a radioactively labelled nucleus was grafted into an unlabelled Amoe-
ba. At 4 h after the operation, the radioactive label had already left the grafted nucleus, and accumulated to a signi¢cant extent in the origi-
nally unlabelled nucleus, with very little labelling present in the cytoplasm. B: Two di¡erent shuttling assays use microinjection. Xenopus oo-
cytes are most often used because, ¢rst, they are easy to inject, and, second, it is possible to manually separate nucleus and cytoplasm.
Microinjection into the nucleus or into the cytoplasm of radioactively labelled proteins allows for a direct quanti¢cation of export and import
rates. Alternatively, antibodies against the protein of interest are microinjected into the cytoplasm. In the case that the antigenic protein does
not shuttle, the antibodies remain exclusively in the cytoplasm (because immunoglobulins do not have a NLS and are too big to di¡use
through the NPC). In the case that the antigenic protein does shuttle, the antibody/antigen complex is imported into the nucleus (the assay is
performed in the presence of protein synthesis inhibitors to rule out the possibility that antibody/antigen complexes form in the cytoplasm with
newly synthesized protein). C: Interspecies heterokaryons are widely used to determine whether or not a nuclear protein shuttles. The basic
principle is to monitor whether, in the presence of protein synthesis inhibitors, the protein originally present in the nucleus of one species ap-
pears in the nucleus of the other species. Monitoring protein migration can be performed using monoclonal antibodies that are speci¢c for one
of the two species. Alternatively, human cells (h) can be transfected with a construct encoding a tagged protein, and fused with mouse cells
(m). The donor and receptor nuclei can be distinguished based on di¡erent chromatin staining patterns, or using an antibody speci¢c for a hu-
man protein that does not shuttle. An important control consists in incubating the donor cells at 4‡C. The protein will remain exclusively nu-
clear if its export is receptor-mediated; detection of the protein in the cytoplasm re£ects passive di¡usion through the NPC. D: A genetic ap-
proach may be performed in yeast cells, using temperature sensitive mutant strains with defects in protein import [59]. Under these conditions,
a nuclear shuttling protein exits the nucleus and accumulates in the cytoplasm.
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plasmic transport events mediated by members of the impor-
tin L family (reviewed by [3,13]). Ran can switch between a
GDP- and GTP-bound state and importin L-related transport
receptors bind speci¢cally to RanGTP. Ran regulates the
binding of substrates (i.e. the cargoes) to the transport recep-
tors. Importins bind to substrates in the absence of Ran, while
export cargoes interact preferentially with the RanGTP-bound
form of exportins. In the presence of RanGTP, importins
release their cargo. Conversely, removal of RanGTP from
an exportin results in displacement of the substrate. To ensure
e⁄cient transport of cargo and recycling of receptors, the
relative concentration of RanGTP and RanGDP in the nu-
cleus and in the cytoplasm is asymmetric. This is accom-
plished by concentrating the RanGTPase activating protein
(RanGAP) in the cytoplasm, and the guanidine nucleotide
exchange factor RCC1 (or RanGEF) in the nucleus. RanGTP
is constantly exported from the nucleus in complexes with
importins and exportins. As these complexes exit the nucleus,
RanGAP localized at cytoplasmic ¢laments of the NPC re-
moves RanGTP from the transport receptors. Ran is then re-
imported into the nucleus in order to replenish the nuclear
stores and allow continued transport cycles. Thus, Ran shut-
tles continuously between nucleus and cytoplasm.
To date, only one major cellular transport pathway appears
to be independent of the importin L family of transporters
and Ran. This is the path responsible for export of spliced
mRNAs to the cytoplasm [15]. Factors required for mRNA
export, which are known to shuttle between nucleus and cy-
toplasm, include the essential yeast protein Mex67p and the
corresponding human homologue TAP (more recently called
NXF1), and yeast Gle2p (human RAE1) [3,4].
3. The role of shuttling proteins in signal transduction pathways
The eukaryotic cell takes advantage of the barrier estab-
lished by the nuclear envelope to control access of transcrip-
tional regulators to their target genes. A simple way to regu-
late transcription of a particular gene in response to a
signalling pathway is to locate an activator protein to the
cytoplasm, until a speci¢c signal triggers its access to the
nucleus. Conversely, genes may be activated in response to
a signal that induces speci¢c inhibitors to exit from the nu-
cleus.
Although re-localization of a protein to the nucleus or to
the cytoplasm in response to a signal does not necessarily
imply that the protein shuttles continuously between nucleus
and cytoplasm, it is becoming clear that most proteins whose
activity is controlled by transport into di¡erent subcellular
compartments are in fact shuttling molecules. Two of the
most recently identi¢ed examples are histone deacetylases
HDAC4 and HDAC5. Histone deacetylases remove acetyl
6
Fig. 2. Transport receptors and adaptors. A: Receptors for classical
NLS and NES-mediated transport. A shuttling protein (blue) with a
classical NLS and a NES binds to importin K (IK) in the cytoplasm.
This will then form a complex with the receptor, importin L (IL),
and RanGDP. The complex interacts with nucleoporins and translo-
cates into the nucleus. The cargo is released, and importin L re-
cycles back to the cytoplasm alone, while importin K requires an ex-
port receptor, CAS-1 (cas). Direct interaction of the NES on the
cargo with the export receptor exportin 1/CRM1 (Xpo) results in
export to the cytoplasm. As most transport receptors, after release
of the cargo, exportin 1 recycles back to the nucleus by itself. B:
Transport receptors of the importin L super-family use di¡erent
adaptors for distinct cargoes. The export adaptor PHAX mediates
interaction of UsnRNAs with exportin 1 [60]. Phosphorylated
PHAX (pPHAX) cooperatively binds the Cap binding complex
(CB) of UsnRNAs and exportin 1. In the cytoplasm, hydrolysis of
RanGTP and dephosphorylation of PHAX will promote the release
of the UsnRNA. After assembly with Sm proteins and modi¢cation
of the cap structure, the resulting snRNPs are imported to the nu-
cleus. The modi¢ed cap structure binds the adaptor Snurportin
(snp) and importin L. C: Export of mRNA is mediated by a dis-
tinct family of export receptors. To date, the best characterized nu-
clear mRNA export factor is TAP(NXF1)/Mex67p. TAP interacts
with nucleoporins (directly or through p15) and its recruitment to
spliced mRNA is probably facilitated by REF/Aly. The hnRNP
proteins (particularly hnRNP A1) are also thought to contribute to
mRNA nuclear export. The 5P cap structure, which binds the Cap
binding complex (CB), is the lead as the mRNA crosses the NPC.
However, there is still no evidence for a direct role of CBC in the
translocation mechanism. It also remains to be determined whether
PABP2 (PAB), which coats the 3P end poly(A) tail, contributes to
mRNA export. Interestingly, both TAP, hnRNP A1 and PABP2
make use of the import receptor transportin (Trp) to recycle back
into the nucleus.
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groups from histones bound to DNA, and HDAC4 was
shown to shuttle into and out of the nucleus. During di¡er-
entiation of skeletal muscle cells in culture, a calcium signal
initiated at the cell membrane activates protein kinases that
add phosphate groups to HDAC4 and HDAC5. The phos-
phorylated enzymes dissociate from MEF2, exposing their
NES. Consequently, export of deacetylases out of the nucleus
prevails over import. MEF2, a muscle-speci¢c transcription
regulator, is then free to activate the expression of muscle-
speci¢c genes [16].
Another example of proteins whose biological activity is
regulated through nucleocytoplasmic shuttling is provided
by the NFUB family of transcription factors. NFUB is nor-
mally composed of two subunits, p50 and p65, which work by
turning on a set of anti-apoptotic genes. The heterodimer p50/
p65 is usually detected predominantly in the cytoplasm, in a
complex with an inhibitor protein called IUB. In response to
appropriate stimuli, the IUB protein becomes phosphorylated
and marked for degradation. As a consequence, NFUB accu-
mulates in the nucleus, binds to target genes and activates a
new program of gene expression. Although it was originally
thought that the NFUB/IUB complex was held captive in the
cytoplasm, recent results indicate that this complex shuttles
continuously between the nucleus and the cytoplasm [17^20].
It is currently suggested that NFUB proteins locate predom-
inantly to the nucleus or to the cytoplasm depending on a
tightly regulated balance between import and export rates.
Regulated nucleocytoplasmic shuttling is also displayed by
the NF-AT transcription factors. In unstimulated T cells, the
NF-AT proteins are cytoplasmic, but they rapidly translocate
into the nucleus in response to T cell receptor activation.
Within the nucleus, NF-AT factors activate transcription of
cytokine genes. Nuclear accumulation of NF-AT proteins is
induced by the calcium-dependent phosphatase calcineurin,
and requires continued calcium signalling. However, nuclear
import is not su⁄cient to activate NF-AT target genes, be-
cause the proteins contain NESs recognized by the CRM1
exportin. In fact, calcineurin was also shown to mask the
NESs present in NF-AT factors [21]. Cessation of the calci-
um-activated signal results in rapid rephosphorylation of NF-
AT by casein kinase I and MEKK1, with consequent export
to the cytoplasm [22]. Based on these data, the following
model was proposed. In the absence of a regulatory mecha-
nism, NF-AT would sequentially interact with importins and
exportins, engaging in a futile cycling across the nuclear enve-
lope that would prevent the functional interaction of NF-AT
transcription factors with target genes. The NF-AT proteins
(and presumably other shuttling proteins) avoid such futile
cycling by coupling the activation of import signals to the
suppression of export signals [21].
Shuttling in and out of the nucleus not only provides a
mechanism to control signal-dependent access of proteins to
nuclear targets, but also contributes to regulate the activity of
proteins in the cytoplasm. In yeast, binding of pheromone to
cell surface receptors activates a protein kinase (mitogen-acti-
vated protein kinase (MAPK)) cascade. Transmission of the
pheromone signal to the kinase cascade in vivo requires prop-
er localization of a sca¡old protein, Ste5, to the plasma mem-
brane. Ste5 shuttles constitutively between nucleus and cyto-
plasm, and its nuclear export is enhanced in the presence of
pheromone [23]. Most important, blocking access of Ste5 to
the nucleus impairs the ability of the protein to localize to the
plasma membrane and to activate the pathway. It was there-
fore proposed that shuttling through the nucleus helps to
prevent recruitment of cytoplasmic Ste5 to the membrane in
the absence of pheromone [23].
Finally, it is noteworthy to highlight that also the kinases
involved in signalling cascades shuttle between nucleus and
cytoplasm. One example is the MAPK (or ERK), a ubiqui-
tous component of signal transduction pathways in eukary-
otes. In unstimulated cells, MAPK/ERK is predominantly
cytoplasmic. Upon activation, the kinase translocates to the
nucleus, where it phosphorylates nuclear targets. Import of
MAPK/ERK to the nucleus depends on its own phosphory-
lation, which in turn promotes homodimerization of the pro-
tein ([24]). Exit of MAPK/ERK from the nucleus is mediated
by MAPK kinase (MAPKK or MEK), which binds MAPK/
ERK, contains NES and shuttles constantly between nucleus
and cytoplasm [25].
4. Shuttling proteins control cell cycle progression and
proliferation
During the past few years it has become well established
that shuttling between nucleus and cytoplasm plays a critical
role in the regulation of cell cycle progression and control of
cellular proliferation. Mitotic events are normally initiated by
the cyclin-dependent kinase Cdc2, which is activated by the
protein phosphatase Cdc25. Cdc25 shuttles in and out of the
nucleus [26,27]. In the presence of DNA damage, Cdc25 is
phosphorylated and this creates a binding site for members
of a family of small acidic proteins collectively called 14-3-3
proteins. Binding of 14-3-3 proteins markedly reduces the nu-
clear import rate of Cdc25, allowing nuclear export to pre-
dominate. As a result, Cdc25 is predominantly located to the
cytoplasm, having no access to Cdc2 present in the nucleus.
Thus, changing the relative rates of nuclear import and export
of Cdc25 in response to DNA damage plays a critical role in
preventing the onset of mitosis while DNA repair is under
way.
Recently, members of the 14-3-3 family of signalling pro-
teins were also found to interact with human TERT, the cat-
alytic subunit of telomerase. Most immortal cells, including
germ cells and cancers, contain active telomerase, which cata-
lyzes de novo synthesis of telomeres. Telomerase activity is
regulated by expression and post-translational modi¢cation
of TERT. TERT contains a NES-like motif and shuttles be-
tween nucleus and cytoplasm. Possibly, 14-3-3 binding inhibits
the interaction of the NES in TERT with the exportin CRM1.
This would lead to accumulation of TERT in the nucleus and
enhancement of telomerase activity on chromosomes [28].
Normal induction and coordination of M phase events in
vertebrate cells involves localizing Cdc2-cyclin B1 to the nu-
cleus during prophase. Cyclin B1 is a shuttling protein and its
nuclear accumulation requires phosphorylation at speci¢c res-
idues. The polo-like kinase 1 was recently identi¢ed as a major
kinase that phosphorylates cyclin B1 at G2/M transition and
during M phase [29]. The polo-like kinase 1-mediated phos-
phorylation seems to be responsible for inactivating the NES
of cyclin B1 rather then enhancing nuclear import of the pro-
tein. This strengthens the view that shuttling proteins can
transiently accumulate either in the nucleus or in the cyto-
plasm depending on a tightly regulated balance between trans-
port into and out of the nucleus.
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Another shuttling protein, p27Kip1, which inhibits Cdk2
complexes in resting cells, must be degraded at the G1/S tran-
sition of the cell cycle [30]. In order to be eliminated, p27Kip1
must ¢rst be imported into the nucleus, where it is phosphor-
ylated by cyclin E-Cdk2 kinase. Phosphorylated p27Kip1 is
then exported to the cytoplasm for degradation.
Coupling exit from the nucleus to cytoplasmic degradation
is also used to control the activity of p53. The p53 protein is a
transcription factor that functions in the nucleus to prevent
the growth of abnormal or damaged cells through several
mechanisms, the best understood of which are activation of
cell cycle arrest and apoptosis. In normally dividing cells it is
necessary to restrain p53 activity by transporting the protein
out of the nucleus. The nucleocytoplasmic transport of p53 is
tightly regulated by its interaction with the shuttling protein
MDM2. Both MDM2 and p53 contain NESs, and it was
recently suggested that ubiquitination of p53 may be neces-
sary for its export, possibly by exposing the NES located in
the C-terminus of the protein [31,32]. According to a current
model, under normal conditions the activity of p53 may be
regulated both by restraining import to the nucleus and by
enhancing exit to the cytoplasm. In response to appropriate
stress signals, nuclear import of p53 is activated while export
is blocked. This model has major implications in understand-
ing the biology of cancers that retain wild-type p53 (approx-
imately 50%). In fact, in a signi¢cant number of tumors with
wild-type p53 (particularly breast cancers and neuroblasto-
mas) the protein appears to be inactive because it is predom-
inantly localized to the cytoplasm.
Similarly to p53, BRCA1 is a tumor suppressor protein
involved in transcriptional regulation and cellular responses
to DNA damage. BRCA1 contains both NLS and NES and
shuttles between nucleus and cytoplasm [33]. It remains to be
established whether mutations in the brca1 gene, which confer
increased susceptibility to breast and ovarian cancers, have
implications on the intracellular tra⁄cking of the protein.
An additional tumor suppressor protein that was recently
shown to shuttle between nucleus and cytoplasm is adenom-
atous polyposis coli (APC) protein [34,35]. Mutational inacti-
vation of the APC protein occurs in most colorectal cancers.
APC suppresses tumor progression by promoting cytoplasmic
degradation of the oncogenic transcriptional activator L-cat-
enin. The APC protein contains highly conserved NESs and
shuttles continuously in and out of the nucleus. APC muta-
tions associated with colon cancer are located adjacent to the
NESs and a¡ect exit of the protein from the nucleus. As a
result, the APC-interacting protein L-catenin accumulates in
the nucleus leading to the activation of transforming genes.
Thus, the ability of APC to shuttle and remove L-catenin
from the nucleus appears to be the basis for its tumor sup-
pression function.
5. Shuttling proteins couple nuclear and cytoplasmic
mRNA metabolism
Within the nucleus, nascent transcripts are packed with
proteins forming ribonucleoprotein particles or RNPs. A sig-
ni¢cant proportion of proteins that bind to mRNA contain
both import and export signals, and shuttle between nucleus
and cytoplasm (reviewed in [4]). A subset of these protein
belongs to the class of nucleocytoplasmic transport factors
implicated in mRNA export. Others are splicing factors that
participate in the regulation of alternative splicing. Some pro-
teins persist associated with the mRNA and license it for
export, while others have a role in cytoplasmic events such
as mRNA localization, mRNA translation, and mRNA turn-
over (reviewed in [9]).
Pin‹ol-Roma and Dreyfuss provided the ¢rst evidence that
some heterogeneous nuclear RNP (hnRNP) proteins, which
coat pre-mRNAs as they are synthesized, shuttle between nu-
cleus and cytoplasm (reviewed by [36]). Shuttling hnRNP pro-
teins include A1, I and K. HnRNP A1, the most extensively
studied, contains a speci¢c type of NES termed M9 [4]. In-
triguingly, the nucleocytoplasmic distribution of shuttling
hnRNPs A1 and I is coupled to transcriptional activity
[37,38]. Under normal conditions, hnRNP A1 and I are ex-
clusively detected in the nucleus, but after inhibition of tran-
scription the proteins accumulate in the cytoplasm. A1 and I
proteins do not contain classical NLSs. In contrast, hnRNPs
C and U do not shuttle, localize in the nucleus independently
of transcriptional activity and contain classical NLSs. Anoth-
er member of the hnRNP family, the K protein, shuttles yet is
transcription-independent and contains the classical NLS. De-
letion of this NLS renders the K protein dependent on on-
going transcription for complete nuclear localization (see [39]
and references therein). A possible interpretation for these
results is that transcription inhibition selectively a¡ects nu-
clear import of hnRNP proteins devoid of a classical NLS
[39]. Alternatively, these proteins re-distribute to the cyto-
plasm when transcription is inhibited because they are no
longer retained in the nucleus by nascent transcripts [40]. Ac-
cording to the latter hypothesis, shuttling is independent of
transcriptional activity. Export to the cytoplasm of hnRNP
proteins devoid of a classical NLS possibly occurs at a faster
rate than import into the nucleus. In a transcriptionally in-
active cell it is expected that the pool of free hnRNP proteins
(i.e. proteins unbound to mRNA) will increase, and these
would be rapidly exported to the cytoplasm. Presence of a
classical NLS most likely increases the rate of import, coun-
teracting the export activity. Consequently, a shuttling protein
with such a ‘dominant’ NLS (like hnRNP K) would be ex-
clusively detected in the nucleus, even in the presence of tran-
scription inhibitors.
Additional proteins that coat mRNAs and shuttle in and
out of the nucleus are poly(A) binding proteins. With only
one known exception, all eukaryotic mRNAs contain a
poly(A) tail at their 3P end. In mammalian cells two distinct
proteins, PABP1 and PABP2, bind to poly(A) tails. PABP1 is
predominantly detected in the cytoplasm, where it is involved
in mRNA stability and translation. PABP2, which is localized
in the nucleus, binds with high a⁄nity to nascent poly(A)
tails, stimulating their extension and controlling their length.
Both PABP1 and PABP2 shuttle between nucleus and cyto-
plasm [41^43], but precisely how PABP2 bound to poly(A)
tails in the nucleus is replaced by PABP1 in the cytoplasm
remains unknown. As 3P end processing appears to be critical
for e⁄cient nuclear export [44], and transport of PABP2 to
the cytoplasm persists in the absence of mRNA tra⁄c, it has
been proposed that shuttling of this protein may contribute to
export of mRNA [43].
The 5P cap structure of mRNAs also enhances the rate of
mRNP export to the cytoplasm. This structure binds the Cap
binding complex, CBC. In yeast, CBC interacts with Npl3p,
an essential hnRNP-like protein with some similarity to SR
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proteins. Both Npl3p and Cbp80p (a component of CBC)
shuttle between nucleus and cytoplasm in a manner dependent
on ongoing synthesis of RNA [45]. Possibly, CBC and Npl3p
escort the mRNA across the NPC and play a role in cytoplas-
mic functions.
A role for shuttling proteins in coupling splicing to mRNA
export has been recently demonstrated [46,47]. The shuttling
protein REF1-I or Aly is a member of the REF family of
evolutionary conserved hnRNP-like proteins (see [48] and
references therein). The yeast homologue of Aly is the
mRNA export factor Yra1p. Human REF, which associates
with mRNAs in a splicing-dependent manner, is recruited
during spliceosome assembly, and then becomes tightly asso-
ciated with the spliced mRNP [46,49]. REF proteins bind
RNA directly and interact with members of the NXF family
of mRNA export factors including metazoan TAP and its
yeast homologue, Mex67p. Thus, REF proteins are thought
to act on mRNA export by recruiting TAP to mRNPs. Like
Aly/REF, Y14 is a shuttling protein that associates preferen-
tially with mRNAs produced by splicing but not with pre-
mRNAs, introns, or mRNAs produced from intronless
cDNAs [47]. Y14 and Aly de¢ne a novel intermediate in the
pathway of gene expression: both proteins are recruited to
spliced mRNPs, promoting export of the mRNA to the cyto-
plasm. Similarly to transport factors, Aly/REF and Y14 are
expected to shuttle in order to recycle back into the nucleus
after escorting the mRNA to the cytoplasm. However, Aly/
REF has the ability to shuttle independently of mRNA export
[48]. One explanation for the shuttling of RNA-free protein is
that binding to RNA may be required for its e⁄cient release
from import receptors in the nucleus. In the absence of RNA
binding, the protein may not dissociate e⁄ciently from the
import receptor and may engage in futile import/export cycles.
This may provide a means for regulating the availability of
mRNA export factors in the nucleus.
Contrasting to Aly/REF and Y14, which appear to be gen-
eral mRNA binding proteins, mRNA-speci¢c shuttling pro-
teins also exist. For example, the mRNAs of many proto-
oncogenes, cytokines and lymphokines are targeted for deg-
radation by AU-rich elements located in their 3P untranslated
regions. A nucleocytoplasmic shuttling protein, termed HuR,
binds selectively to these elements stabilizing the mRNAs [50].
Possibly, HuR binds to AU-rich element-containing mRNAs
in the nucleus and accompanies them to the cytoplasm, pro-
viding protection against degradation. Stability of these
RNAs is subject to regulation, and several lines of evidence
suggest the involvement of signal transduction pathways.
More recently, HuR was shown to interact with two shuttling
phosphoproteins, pp32 and APRIL, that interact with the
nuclear export receptor CRM1. Furthermore, the inhibition
of CRM1 by leptomycin B leads to selective retention in the
nucleus of c-fos, an AU-rich element-containing mRNA. This
raises the possibility that particular mRNAs may have a dedi-
cated export pathway regulated by speci¢c shuttling proteins
[51].
Additional mRNA binding proteins that shuttle between
nucleus and cytoplasm include splicing factors and Upf pro-
teins involved in nonsense-mediated decay (NMD) (reviewed
by [9]). In NMD, aberrant transcripts containing premature
stop codons are degraded [52]. Typically, premature termina-
tion codons are present in internal exons and it is currently
thought that recognition of an intron downstream of a stop
codon is critical to trigger NMD. Very recent data suggest
that nuclear Upf proteins assemble in a complex at mRNA
exon^exon junctions and trigger NMD in the cytoplasm when
recognized downstream of a translation termination site [53].
Exonic sequences additionally contain binding sites for SR
proteins, a family of essential pre-mRNA splicing factors.
Some members of the SR protein family shuttle in and out
of the nucleus, presumably because they remain bound to
mRNAs in transit to the cytoplasm. In fact, stable binding
to mRNA is essential for shuttling of these factors [54]. More
recently, the U2 snRNP auxiliary factor (U2AF) was also
shown to shuttle between nucleus and cytoplasm [55]. In con-
trast to SR proteins, U2AF binds to intronic sequences in the
pre-mRNA and dissociates from the spliceosome during the
splicing reaction. Thus, it appears unlikely that U2AF accom-
panies the mRNA to the cytoplasm. Supporting this view,
shuttling of U2AF is independent of mRNA binding and
continues in the absence of mRNA tra⁄c [55].
Several possibilities have been envisaged to explain the
shuttling of splicing factors. In the case of SR proteins, the
association with spliced mRNPs could serve as a marker or
guide to the transport machinery. Indeed, two shuttling SR
proteins (SRp20 and 9G8) have recently been suggested to act
as adaptors for the nuclear export of spliced cellular mRNAs
[56]. Alternatively, SR proteins could remain bound to the
mRNAs in the cytoplasm and play a role as regulators of
mRNA stability or translation. In the case of U2AF, which
exits the nucleus independently of mRNA, the possibility re-
mains that this factor plays an as yet undetermined role in the
cytoplasm. Most important, shuttling of both SR proteins and
U2AF could provide a mechanism to control nuclear avail-
ability of splicing factors in response to external signals, thus
allowing for a rapid tuning of splicing activity. Indeed, alter-
native splice decisions can be determined by changing the rel-
ative concentration of proteins that play antagonistic roles in
the selection of splice sites [57]. A potential role of shuttling in
regulation of alternative splicing is supported by the recent
observation that cytoplasmic accumulation of the shuttling
protein hnRNPA1 occurs in response to cellular stress and
correlates with changes in alternative splicing [58].
6. Perspectives
Nucleocytoplasmic shuttling of proteins plays a major role
in controlling gene expression. Although it was initially
thought that regulatory factors are held captive in either the
nucleus or the cytoplasm, until an appropriate signal triggers
transport to the other side of the nuclear envelope, several
lines of recent evidence indicate that most of these proteins
are in fact constantly moving in and out of the nucleus. How-
ever, at steady state they accumulate predominantly in the
nucleus or in the cytoplasm, depending on the balance be-
tween import and export rates. Compared to the model of
retention versus transport, continuous shuttling may allow
for a tighter regulation of protein activity. First, interaction
of the shuttling protein with transport receptors most likely
generates inactive complexes, preventing action in the absence
of appropriate signals. Second, the existence of a permanent
pool of the protein in both compartments favors a more rapid
association to target molecules upon signal induction, without
the delay associated with translocation across the nuclear en-
velope. Interfering with nucleocytoplasmic shuttling opens a
FEBS 24912 5-6-01 Cyaan Magenta Geel Zwart
M. Gama-Carvalho, M. Carmo-Fonseca/FEBS Letters 498 (2001) 157^163162
novel and exciting window to manipulate cellular commit-
ments, and repercussions in cancer therapy are expected to
follow the recent discovery that failure in import/export path-
ways is on the basis of tumor development.
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